Caffeine content in newborn hair correlates with maternal dietary intake.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 09 10 2019
accepted: 18 03 2020
pubmed: 5 4 2020
medline: 24 6 2021
entrez: 5 4 2020
Statut: ppublish

Résumé

High-maternal caffeine intake during pregnancy may be harmful for perinatal outcomes and future child health, but the level of fetal cumulative exposure has been difficult to measure thus far. Here, we present maternal dietary caffeine intake during the last trimester and its correlation to caffeine content in newborn hair after birth. Maternal third trimester diets and dietary caffeine intake were prospectively collected in Kuopio Birth Cohort (KuBiCo) using a 160-item food frequency questionnaire (n = 2840). Newborn hair was collected within 48 h after birth and analyzed by high-resolution mass spectrometry (HRMS) for caffeine (n = 316). Correlation between dietary caffeine intake and neonatal hair caffeine content was evaluated from 203 mother-child pairs. Mean dietary caffeine intake was 167 mg/days (95% CI 162-172  mg/days), of which coffee comprised 81%. Caffeine in the maternal diet and caffeine content in newborn hair correlated significantly (r = 0.50; p < 0.001). Older, multiparous, overweight women, and smokers had the highest caffeine levels in the maternal diet, as well as in their newborn babies' hair. Caffeine exposure, estimated from newborn hair samples, reflects maternal third trimester dietary caffeine intake and introduces a new method to assess fetal cumulative caffeine exposure. Further studies to evaluate the effects of caffeine exposure on both perinatal and postnatal outcomes are warranted, since over 40% of pregnant women consume caffeine more than the current suggested recommendations (European Food Safety Association, EFSA recommendations).

Identifiants

pubmed: 32246261
doi: 10.1007/s00394-020-02231-2
pii: 10.1007/s00394-020-02231-2
pmc: PMC7867507
doi:

Substances chimiques

Coffee 0
Caffeine 3G6A5W338E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-201

Références

Drug Test Anal. 2014 Jun;6 Suppl 1:5-8
pubmed: 24817042
Obstet Gynecol. 2015 Oct;126(4):725-730
pubmed: 26348183
BMC Pregnancy Childbirth. 2018 Sep 21;18(1):381
pubmed: 30241516
BMC Med. 2013 Feb 19;11:42
pubmed: 23421532
Eur J Epidemiol. 2014 Oct;29(10):725-34
pubmed: 25179792
Anal Bioanal Chem. 2012 May;403(5):1233-49
pubmed: 22179491
J Pharm Biomed Anal. 2014 Jan;88:295-306
pubmed: 24095804
Am J Clin Nutr. 2010 Jun;91(6):1691-8
pubmed: 20427730
Talanta. 2015 Nov 1;144:62-70
pubmed: 26452792
BMJ. 2008 Nov 03;337:a2332
pubmed: 18981029
Nutrients. 2018 Aug 08;10(8):
pubmed: 30096771
Clin Epidemiol. 2017 Dec 15;9:699-719
pubmed: 29276412
Physiol Behav. 2011 Aug 3;104(2):348-53
pubmed: 21397617
Forensic Sci Int. 2010 Mar 20;196(1-3):27-31
pubmed: 20074880
Rev Bras Ginecol Obstet. 2018 Dec;40(12):749-756
pubmed: 30536269
Int J Gynaecol Obstet. 2015 Aug;130(2):116-22
pubmed: 26026343
Front Biosci. 2004 May 01;9:1348-59
pubmed: 14977550
Nutrients. 2018 Aug 23;10(9):
pubmed: 30142937
J Clin Epidemiol. 1996 Apr;49(4):401-9
pubmed: 8621990
Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):220-4
pubmed: 21636205

Auteurs

Anni Lehtonen (A)

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

Lauri Uusitalo (L)

Institute of Clinical Medicine, School of Medicine, University of Eastern Finland, Kuopio, Finland. lauriuus@uef.fi.
Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland. lauriuus@uef.fi.

Seppo Auriola (S)

LC-MS Metabolomics Center, Biocenter, Kuopio, Finland.

Katri Backman (K)

Institute of Clinical Medicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland.

Seppo Heinonen (S)

Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Leea Keski-Nisula (L)

Institute of Clinical Medicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland.

Markku Pasanen (M)

School of Pharmacy, University of Eastern Finland, Kuopio, Finland.

Juha Pekkanen (J)

Department of Public Health, University of Helsinki, Helsinki, Finland.
Environmental Health Unit, National Institute for Health and Welfare, Helsinki, Finland.

Tomi-Pekka Tuomainen (TP)

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

Raimo Voutilainen (R)

Institute of Clinical Medicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland.

Sari Hantunen (S)

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

Marko Lehtonen (M)

LC-MS Metabolomics Center, Biocenter, Kuopio, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH